Primary Lateral Sclerosis Latest Advances
Find the Latest Research About Primary Lateral Sclerosis
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48486 publications
The Role of overdose Folic Acid in Promoting Neuroinflammation, Oxidative Stress, and Apoptosis in SOD1-G93A Mice.
Journal: Free radical research
Published: September 06, 2026
Delayed diagnosis and genetic testing in spinal muscular atrophy: a case series.
Journal: Annals of medicine
Published: September 06, 2026
Autophagy Deficits in Lower Motor Neuron and Striated Muscle Diseases: From Genetics to Therapeutic Advances.
Journal: Annual review of pathology
Published: September 03, 2026
Repairing the Amyotrophic Lateral Sclerosis Trial Credibility Gap.
Journal: Neurology
Published: September 02, 2026
Proteomic and Functional Signatures of Phenoconversion in Presymptomatic Amyotrophic Lateral Sclerosis.
Journal: Journal of clinical neuromuscular disease
Published: September 02, 2026
Mitophagy in neuronal health and disease: from mechanisms to neurodegeneration.
Journal: The Journal of clinical investigation
Published: September 01, 2026
Atypical forms of amyotrophic lateral sclerosis
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: September 01, 2026
Computational Insights into Neuromodulation: How Electric Fields Shape Motor Neuron Excitability.
Journal: IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society
Published: August 31, 2026
Cognitive and behavioral manifestations of the C9orf72 mutation in Amyotrophic Lateral Sclerosis: an age, education, and gender-matched cohort study.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: August 28, 2026
High-dose methylcobalamin in amyotrophic lateral sclerosis: mechanistic rationale, translational evidence, and clinical implications.
Journal: Neurodegenerative disease management
Published: August 27, 2026
Delphi consensus on gene therapy of spinal muscular atrophy with onasemnogene abeparvovec in Germany, Austria and Switzerland - part II - expert based recommendations for surveillance and management of side-effects.
Journal: Journal of neuromuscular diseases
Published: August 27, 2026
Immune Cell-Specific SMN Expression and Sustained Immune Alterations in Treated Spinal Muscular Atrophy.
Journal: The Journal of clinical investigation
Published: August 25, 2026
Last Updated: 09/26/2026